Scientists have found that genetic changes in bowel tumours are linked to the way the body's immune system responds to the cancer, according to research published today in the journal Oncoimmunology.
For the first time, Cancer Research UK researchers at the University of Birmingham have found that certain genetic flaws in bowel cancer are more likely to trigger an immune response at the site of tumours, meaning that treatments to boost this immune response further could potentially be helpful for these patients.
Finding out what's happening in a cancer patient's immune system can be difficult and takes time. These findings suggest that genetic profiles of patients' tumours could be used as an easy and fast way of diagnosing whether they are suitable for immunotherapy treatments, and if so which ones.
Cancer Research UK's FOCUS4 trial is already using the genetics of bowel cancer to offer patients stratified medicine and this study suggests that we could further expand this work to include immunotherapies.
Gary Middleton, Professor of Medical Oncology at the School of Cancer Sciences at the University of Birmingham, said: "The field of immunotherapy is gaining lots of momentum and this study shows a new finding for bowel cancer. We are already using genetic profiling for stratified medicine in bowel cancer in the FOCUS4 trial. But this research indicates that we could marry immunotherapy with the work we are already doing to personalise treatment even more."
Researchers used The Cancer Genomic Atlas, a large database, to study this relationship. From this research, scientists can now start looking at what causes a weak immune response and in the future, could target drugs to switch off the immune suppression associated with certain genetic mutations.
Nell Barrie, senior science communication manager at Cancer Research UK, said: "This study shows a strong association between certain genetic profiles and immune responses, but we don't yet fully understand this link. Further research to investigate the fundamentals behind different immune responses could open new doors in drug development."
Explore further: Immune system 'œfriendly fire' could be to blame for bowel cancer deaths
Medical Xpress on facebook
Related Stories
Immune system 'œfriendly fire' could be to blame for bowel cancer deaths
Feb 18, 2015
New research suggests that patients recovering from bowel cancer surgery may be at a higher risk of relapse if their blood shows an immune response to a particular protein, called carcinoembryonic antigen ...
New immunotherapy drug 'fast-tracked' for melanoma patients
Mar 12, 2015
A new immunotherapy drug, pembrolizumab, has become the first treatment 'fast-tracked' for NHS patients with advanced melanoma, under a new Government scheme.
Study confirms long-term benefits of melanoma immunotherapy
Feb 25, 2015
A long-term follow up of people on an international clinical trial has confirmed the benefit of immunotherapy for certain patients with advanced (stage 3 or 4) melanoma.
Study makes case for wider gene testing in bowel cancer
Jan 05, 2015
Up to a quarter of patients with bowel cancer who have a family history of the disease could have the causes of their cancer identified through gene testing, a new study reports.
Engineered cells could help tackle the third most common cancer in Chinese males
Mar 10, 2015
Researchers at the University of Birmingham believe that a new method of genetically engineering immune cells could lead to improved treatment of Nasopharyngeal carcinoma (NPC) patients.
Recommended for you
Vitamin D may keep low-grade prostate cancer from becoming aggressive
14 hours ago
Taking vitamin D supplements could slow or even reverse the progression of less aggressive, or low-grade, prostate tumors without the need for surgery or radiation, a scientist will report today.
Popular weed killer deemed probable carcinogen by UN
Mar 20, 2015
One of the world's most popular weed-killers—and the most widely used kind in the U.S.—has been labeled a probable carcinogen by the International Agency for Research on Cancer.
Researchers combat prostate cancer at cellular level
Mar 20, 2015
Florida International University scientists are battling prostate cancer at the cellular level. Researchers from FIU's Biomolecular Sciences Institute (BSI) believe they can eradicate prostate cancer that returns in patients who wer ...
Researchers ID potential prognostic marker for recurrence of head and neck squamous cell carcinoma
Mar 20, 2015
A new study provides the first evidence that the mediator complex subunit 15 (MED15) may play a crucial role in the pathophysiology of head and neck squamous cell carcinoma (HNSCC). MED15 overexpression was found to be associated ...
Skin cancer rates rise for hispanic, asian women
Mar 20, 2015
(HealthDay)—While most white people who develop skin cancer are older men, the reverse is true in Asian and Hispanic populations, a new study suggests.
Breastfeeding may offset leukemia risk
Mar 20, 2015
Breastfeeding could help reduce the risk of acute lymphoblastic leukemia in children, according to a WA-led study.
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here to reset your password.
Sign in to get notified via email when new comments are made.
© Medical Xpress 2011-2014, Science X network
Scientists have found that genetic changes in bowel tumours are linked to the way the body's immune system responds to the cancer, according to research published today in the journal Oncoimmunology.
For the first time, Cancer Research UK researchers at the University of Birmingham have found that certain genetic flaws in bowel cancer are more likely to trigger an immune response at the site of tumours, meaning that treatments to boost this immune response further could potentially be helpful for these patients.
Finding out what's happening in a cancer patient's immune system can be difficult and takes time. These findings suggest that genetic profiles of patients' tumours could be used as an easy and fast way of diagnosing whether they are suitable for immunotherapy treatments, and if so which ones.
Cancer Research UK's FOCUS4 trial is already using the genetics of bowel cancer to offer patients stratified medicine and this study suggests that we could further expand this work to include immunotherapies.
Gary Middleton, Professor of Medical Oncology at the School of Cancer Sciences at the University of Birmingham, said: "The field of immunotherapy is gaining lots of momentum and this study shows a new finding for bowel cancer. We are already using genetic profiling for stratified medicine in bowel cancer in the FOCUS4 trial. But this research indicates that we could marry immunotherapy with the work we are already doing to personalise treatment even more."
Researchers used The Cancer Genomic Atlas, a large database, to study this relationship. From this research, scientists can now start looking at what causes a weak immune response and in the future, could target drugs to switch off the immune suppression associated with certain genetic mutations.
Nell Barrie, senior science communication manager at Cancer Research UK, said: "This study shows a strong association between certain genetic profiles and immune responses, but we don't yet fully understand this link. Further research to investigate the fundamentals behind different immune responses could open new doors in drug development."
Explore further: Immune system 'œfriendly fire' could be to blame for bowel cancer deaths
Medical Xpress on facebook
Related Stories
Immune system 'œfriendly fire' could be to blame for bowel cancer deaths
Feb 18, 2015
New research suggests that patients recovering from bowel cancer surgery may be at a higher risk of relapse if their blood shows an immune response to a particular protein, called carcinoembryonic antigen ...
New immunotherapy drug 'fast-tracked' for melanoma patients
Mar 12, 2015
A new immunotherapy drug, pembrolizumab, has become the first treatment 'fast-tracked' for NHS patients with advanced melanoma, under a new Government scheme.
Study confirms long-term benefits of melanoma immunotherapy
Feb 25, 2015
A long-term follow up of people on an international clinical trial has confirmed the benefit of immunotherapy for certain patients with advanced (stage 3 or 4) melanoma.
Study makes case for wider gene testing in bowel cancer
Jan 05, 2015
Up to a quarter of patients with bowel cancer who have a family history of the disease could have the causes of their cancer identified through gene testing, a new study reports.
Engineered cells could help tackle the third most common cancer in Chinese males
Mar 10, 2015
Researchers at the University of Birmingham believe that a new method of genetically engineering immune cells could lead to improved treatment of Nasopharyngeal carcinoma (NPC) patients.
Recommended for you
Vitamin D may keep low-grade prostate cancer from becoming aggressive
14 hours ago
Taking vitamin D supplements could slow or even reverse the progression of less aggressive, or low-grade, prostate tumors without the need for surgery or radiation, a scientist will report today.
Popular weed killer deemed probable carcinogen by UN
Mar 20, 2015
One of the world's most popular weed-killers—and the most widely used kind in the U.S.—has been labeled a probable carcinogen by the International Agency for Research on Cancer.
Researchers combat prostate cancer at cellular level
Mar 20, 2015
Florida International University scientists are battling prostate cancer at the cellular level. Researchers from FIU's Biomolecular Sciences Institute (BSI) believe they can eradicate prostate cancer that returns in patients who wer ...
Researchers ID potential prognostic marker for recurrence of head and neck squamous cell carcinoma
Mar 20, 2015
A new study provides the first evidence that the mediator complex subunit 15 (MED15) may play a crucial role in the pathophysiology of head and neck squamous cell carcinoma (HNSCC). MED15 overexpression was found to be associated ...
Skin cancer rates rise for hispanic, asian women
Mar 20, 2015
(HealthDay)—While most white people who develop skin cancer are older men, the reverse is true in Asian and Hispanic populations, a new study suggests.
Breastfeeding may offset leukemia risk
Mar 20, 2015
Breastfeeding could help reduce the risk of acute lymphoblastic leukemia in children, according to a WA-led study.
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here
to reset your password.
Sign in to get notified via email when new comments are made.
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment